NewsRx

Search our medical news database

Artes Medical, Inc.

Artes Medical Reports Preliminary Record Second Quarter 2008 ArteFill Revenues

Published in Medical Letter on the CDC and FDA, July 27th, 2008

Artes Medical, Inc. (Nasdaq:ARTE), a medical aesthetics company, announced preliminary record revenues for the second quarter of 2008 from sales of its flagship product, ArteFill, the first and only FDA-approved non-resorbable dermal filler for the correction of smile lines.

Based on preliminary financial data, the Company will report record ArteFill sales of approximately $3.2 million for the second quarter of 2008, representing an approximate 56% increase in ArteFill sales from the second quarter of 2007 and an approximate 93% increase in ArteFill sales from the first quarter of 2008.

Christopher J. Reinhard, Executive Chairman reported that "the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook